Citi raised the firm’s price target on Boston Scientific (BSX) to $107 from $98 and keeps a Buy rating on the shares. The firm also added the ...

Intera’s portfolio consists of Intera 3000 Hepatic Artery Infusion Pump, which is used to administer chemotherapy in liver ...

Canaccord raised the firm’s price target on Boston Scientific (BSX) to $101 from $98 and keeps a Buy rating on the shares. Canaccord said they ...

The day after completing its latest billion-dollar deal, Boston Scientific dispatched food trucks to hand out fried chicken sandwiches and burritos to Silk Road Medical employees in California and ...

This particularly applies to tech giants and popular consumer-facing stocks. What if you'd invested in Boston Scientific (BSX) ten years ago? It may not have been easy to hold on to BSX for all that ...

Boston Scientific today announced the appointment of Xavier Bertrand as president and SVP for the EMEA region.

Boston Scientific (BSX) ended the recent trading session at $90.53, demonstrating a -0.34% swing from the preceding day's closing price. This change lagged the S&P 500's 0.19% loss on the day.

Boston Scientific BSX has outperformed the market over the past 10 years by 10.11% on an annualized basis producing an average annual return of 21.27%. Currently, Boston Scientific has a market ...

Boston Scientific officially closed its multibillion-dollar acquisition of Axonics roughly 10 months after announcing the proposal. The deal is valued at $71 per share, representing $3.7 billion ...

Boston Scientific, a Marlborough medical device manufacturer, has officially closed its acquisition of Axonics, Inc. after entering into a purchase agreement in January. Axonics, a publicly ...

Boston Scientific Corporation announced it has entered into a definitive agreement to acquire Intera Oncology Inc. Boston ...